Moreover, we identified an active enhancer element whose activity is regulated by AD risk alleles located at a distance from it and which is strongly associated with expression of AP4E1 and SPPL2A in monocytes (Fig. 3c). This evidence concerns the gene SPPL2A and Alzheimer disease.